National cohort study on cardiometabolic index and incident stroke in middle-aged and older adults in China

HaiXia He1, DanDan Li2, LiangYing Liao1

  • 1The First Hospital of Hunan University of Chinese Medicine, Changsha, China.

Insights

The Cardiometabolic Index (CMI) is linked to higher stroke risk in older Chinese adults. This marker can help predict and prevent strokes in public health initiatives.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Public Health

Background:

  • The Cardiometabolic Index (CMI) integrates central obesity and lipid metabolism.
  • CMI is a marker for metabolic health, linked to diabetes and cardiovascular diseases.
  • CMI's role in stroke risk prediction is not well-established.

Purpose of the Study:

  • To investigate the association between CMI and stroke risk.
  • To assess CMI as a predictive tool for stroke in Chinese adults aged 45+.

Main Methods:

  • Analysis of data from the China Health and Retirement Longitudinal Study (CHARLS).
  • Participants categorized into CMI quartiles; stroke incidence as primary endpoint.
  • Cox proportional hazards models, Kaplan-Meier curves, and restricted cubic splines (RCS) used for analysis.

Main Results:

  • 7,821 participants followed for 7 years; 418 strokes observed.
  • Higher CMI significantly associated with increased stroke risk (HR=1.153, P=0.004).
  • RCS showed a non-linear increase in stroke risk with rising CMI (P=0.005).

Conclusions:

  • Elevated CMI correlates with increased stroke risk in middle-aged and older Chinese adults.
  • Integrating CMI into routine assessments may enhance early stroke prevention.
  • This approach can help manage the growing burden of cerebrovascular disease.

Related Concept Videos

Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
49.1K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
258
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
23